Human Leukocyte Antigen-B27: The Genetic Predisposition Leading to Reactive Arthritis during Induction Phase Chemotherapy for Acute Myeloid Leukemia

We report a case of reactive arthritis (ReA) during induction phase chemotherapy of a 15-year-old male patient with acute myeloid leukemia (AML) M4 with inv(16), most probably due to a genetic predisposition of being human leukocyte antigen b27 (HLA-B27) positive. The episode of ReA recurred during...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartakke, Sandip P, Sampagar, Abhilasha Ashok, Bafna, Vibha Sanjay, Patel, Putun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686989/
https://www.ncbi.nlm.nih.gov/pubmed/29200696
http://dx.doi.org/10.4103/ijmpo.ijmpo_8_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686989/
https://www.ncbi.nlm.nih.gov/pubmed/29200696
http://dx.doi.org/10.4103/ijmpo.ijmpo_8_17

Ejemplares similares